-
Presenter: Ralph Carson, LD, RD, PhD
-
CME: 1.25 AMA PRA Category 1 Credits™
-
Price: $69
-
Format: 1 hour video lecture
Overview
Research suggests that almost 90% of Americans are exposed to at least one potentially traumatic event during their lives (Kirkpatrick ’13). Insomnia is one of the most common sleep issues related to trauma. It’s normal for a traumatic experience to affect the quantity and quality of sleep. More severe and persistent sleep disorders are associated with PTSD and both are predominant in the eating disorder and mood and anxiety population. Since PTSD is a condition characterized by recurrent and involuntary memories of the traumatic event (flashbacks, nightmares), it makes sense that introducing treatment strategies aimed at improving sleep should play a pivotal role in recovery. Researchers have found evidence that multiple overlapping brain regions are implicated in both PTSD and sleep problems.
This course addresses how memory consolidation during sleep is responsible for many of the consequences experienced by people struggling with trauma/PTSD. Treating sleep is necessary for effective trauma resolution and this overview of trauma presents timely interventions (Imagery rehearsal therapy (IRT), exposure response prevention (ERP), rescripting, relaxation therapy (ERRT), sleep hygiene; cognitive behavioral treatment for insomnia (CBT-I); unique pharmacological therapy (α and β- adrenergic blockers). Furthermore, this talk will provide an unlikely and underutilized treatment for trauma/PTSD and expound on the sleep dysregulation that trauma generates.
Learning Objectives
- Identify the different brain areas and pathways that can be disrupted from trauma and how they overlap with sleep
- Assess how disrupted sleep can worsen trauma and contribute to PTSD
- Describe the ways that quality sleep can be therapeutic for trauma
- Incorporate strategies for reducing or eliminating nightmares and for improving sleep
Accreditation Information
Please click to expand each section and view accreditation information.
• CME Information
DURATION OF ACTIVITY
June 20, 2022 through June 19, 2024
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedicusCME and Comprehensive Psychiatric Resources, Inc. MedicusCME is accredited by the ACCME to provide continuing medical education for physicians.
DESIGNATION STATEMENT
MedicusCME designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OVERVIEW
Trauma often causes ongoing mental health issues and sleep disturbances. Resolving sleep disorders is often critical for recovery after trauma. This course explores the intertwined relationship between trauma and sleep, along with potential interventions focused on improving sleep to facilitate trauma recovery.
HOW TO CLAIM CREDIT
In order to receive AMA PRA Category 1 credit™, participants must do the following:
-
Read the learning objectives and faculty disclosures
-
Participate in the activity, review course content and learning strategies, resources and support materials provided
-
Complete the post-test and activity evaluation
- Achieve a score of 80% or higher on the post-test
PLANNER CONTENT EXPERT
James Greenblatt, MD
Chief Medical Officer and Vice President of Medical Services
Walden Behavioral Care, Waltham, Massachusetts
Assistant Clinical Professor of Psychiatry
Tufts University School of Medicine
Boston, Massachusetts
FACULTY CONTENT EXPERT
Ralph Carson, CED-RD, RD, PhD
Senior Clinical and Research Advisor, Eating Recovery Center-Pathlight Mood and Anxiety
Clinical Nutritional Advisor, Pine Grove Behavioral Health and Addiction Services
Hattiesburg, Mississippi
DISCLOSURE OF FINANCIAL RELATIONSHIPS
MedicusCME requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to MedicusCME policy.
James Greenblatt, MD has disclosed a financial relationship with Pure Encapsulations and Jaymac Pharmaceuticals for his role as consultant.
All other faculty and planners, as well as MedicusCME planners and managers, have no relevant financial relationships with ineligible companies to disclose. Any relevant financial relationships listed for planners or content contributors have been mitigated according to MedicusCME policies.
ACKNOWLEDGEMENTS
This activity is not supported by funds from an ACCME-defined ineligible company.
HIPPA COMPLIANCE ATTESTATION
In accordance with the Health Insurance Portability and Accountability Act (HIPAA), this educational activity, especially when utilizing patient cases for learning demonstration, will not include individually identifiable health information.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Let’s redefine mental wellness together.
Sign-up now for the latest in functional news and research, course launches, exclusive offers and more.
By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.
